FHL2 and neoplasm: Multivariate analysis further identified tumour, node, metastasis stage and FHL2 level (HR: 1.470, 95% CI: 1.093–1.978, p = 0.011) as independent prognostic factors for OS (Table 2), while tumor stage (III versus I) and FHL2 level (HR: 1.545, 95% CI: 1.078–2.213, p = 0.018) were independent prognostic factors for DFS (Table 3).